2 completed, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Terminated 1 |
Follow Lung Disease: new trials by email Literature Review of Lung Disease trials Research Report on Lung Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PleuraSeal Post Market Study (Europe) Standard Tissue Closure Techniques, PleuraSeal Lung Sealant System - Lung Disease, Pulmonary Lobectomy | Phase 4 | Completed | Integra LifeSciences Corporation | 121 | 2008-01-01 | 2016-10-27 |
| Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair Placebo, Xolair - Lung Disease | Phase 4 | Completed | Creighton University | 65 | 2005-09-01 | 2014-01-07 |
| Natrecor in Pulmonary Hypertension Nesiritide (Natrecor), Right Heart Catheterization - Pulmonary Hypertension, Cancer | Phase 4 | Terminated | M.D. Anderson Cancer Center | 15 | 2003-12-31 | 2018-11-07 |
Lung Diseases (3) · Hypertension, Pulmonary (1) · Lung Neoplasms (1) · Neoplasms (1)
Respiratory Tract Diseases (3) · Cardiovascular Diseases (1) · Hypertension (1) · Neoplasms by Site (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1) · Vascular Diseases (1)
Natriuretic Peptide, Brain (1) · Omalizumab (1) · Saline Solution (1) · Sutures (1)
Creighton University (1) · Integra LifeSciences Corporation (1) · M.D. Anderson Cancer Center (1)
United States (3) · Austria (1) · Belgium (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
Daniel J. Lenihan, MD (1) · Jennifer Doyle (1) · Muhammad A Pasha, M.D. (1) · Paul De Leyn, MD, PhD (1) · Robert G Townley, MD (1)